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Background. Up to 98% of visual loss secondary to diabetic retinopathy (DR) can be prevented with early detection and treatment.
Despite this, less than 50% of Australian and American diabetics receive appropriate screening. Diabetic patients living in rural
and remote communities are further disadvantaged by limited access to ophthalmology services. Research Design andMethods. DR
screening using a nonmydriatic fundal camera was performed as part of a multidisciplinary diabetes service already visiting remote
communities. Images were onforwarded to a distant general practitioner who identified and graded retinopathy, with screen-
positive patients referred to ophthalmology.This retrospective, descriptive study aims to compare the proportion of remote diabetic
patients receiving appropriate DR screening prior to and following implementation of the service. Results. Of the 141 patients
in 11 communities who underwent DR screening, 16.3% had received appropriate DR screening prior to the implementation of
the service. In addition, 36.2% of patients had never been screened. Following the introduction of the service, 66.3% of patients
underwent appropriate DR screening (𝑝 = 0.00025). Conclusion. This innovative model has greatly improved accessibility to DR
screening in remote communities, thereby reducing preventable blindness. It provides a holistic, locally appropriate diabetes service
and utilises existing infrastructure and health workforce more efficiently.
1. Introduction
In 2013, there were 382 million people with diabetes world-
wide and it is predicted that this will increase to 592 million
people by 2035 [1]. Diabetic retinopathy (DR) is the most
serious ocular complication of diabetes and is the leading
cause of preventable blindness in working age populations
[2]. DR accounted for 5% of global blindness in 2002, approx-
imately five million people worldwide [3]. It is estimated that
up to 50% of people with proliferative DR who do not receive
timely treatment will become legally blind within five years
[4]. Although up to 98% of visual loss secondary to DR can
be prevented with early detection and treatment, once it has
progressed, vision loss is often permanent [5]. Despite this,
comprehensive DR screening rates are poorly achieved glob-
ally, with less than 50% of Australian and American diabetic
patients receiving appropriate screening [6, 7]. The number
of people with diabetes living in rural areas is increasing
worldwide and is expected to reach 145 million people by
2035 [1]. Patients living in rural and remote areas have poorer
access to specialist ophthalmology services [8, 9]. Indigenous
people worldwide are particularly vulnerable to eye disease,
with blindness six times higher in Indigenous Australians
than for non-Indigenous Australians [1, 10]. Impaired vision
affects national economies through loss of productivity and
earning capacity as well as having significant negative social
impacts on communities worldwide, with vision impaired
individuals relying heavily on social support [1].
A review of international rural remote DR screening
models by the authors found that the vast majority of
publishedmodels use ophthalmologists as the primary image
graders. Given the growing number of diabetic patients
worldwide, poor achievement of screening recommenda-
tions, and limited access to ophthalmology services in rural
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Table 1: The documented diabetic population in remote communities visited by the screening program.
Remote community
2012 2013 2014
Documented
diabetic population
(𝑛)
Patients
screened
(𝑛)
Documented
diabetic population
(𝑛)
Patients
screened
(𝑛)
Documented
diabetic population
(𝑛)
Patients
screened
(𝑛)
1 37 11 46 12 No screening∗
2 10
(2013)
4 No screening No screening∗
3 3
(2013)
3 3 4 No screening∗
4 8 5 8
(2012)
7 8
(2012)
4
5 10 2 10
(2012)
1 10 6
6 15 5 16 8 14 7
7 39 13 49 18 35 17
8 32 9 22 17 27 10
9 7
(2013)
1 7 1 13 8
10 26 10 26 10 18 9
11 15 5 14 5 15 6
Total 202 68 201 83 140 67
Diabetic population
screened (%) 33.7% 41.3% 47.9%
Note: where no data was available on the diabetic population in a particular community from a specific year, the diabetic population is used from a previous
year and indicated with the year in subscript.
Note: the diabetic population was documented from community health records. Lists were obtained from a chronic disease database and updated by PHCs
and the regional diabetes educator. Patients were excluded if they were deceased or had moved from the district.
∗These communities were screened early in 2015 due to changeover of the eye screening coordinator.
and remote communities, there is a recognised need for
innovative approaches to the delivery of DR screening. This
has led to trials utilising nonophthalmologist graders, with
numerous studies demonstrating the efficacy of nonoph-
thalmologist graders in detecting DR [4, 11–15]. This paper
presents the results of the evaluation of an innovative remote
outreach DR screening (RODRS) service delivered in remote
communities in a state of Australia. The service aims to
improve rates of DR screening for patients in remote settings
with previously limited access to screening.
2. The Remote Outreach DR Screening
(RODRS) Service
2.1. Existing Service. In 2012, the RODRS service was imple-
mented in a Hospital District and Health Service in a state
of Australia. Prior to 2012, visiting ophthalmologists and
optometrists performed the majority of DR screening in the
district. The implementation of the service was prompted
by concerns that diabetic patients living in the region
were not undergoing DR screening, and to utilise visiting
ophthalmology services more efficiently. Optometrists and
ophthalmologists service four rural and three remote com-
munities in the region, with ophthalmologists visiting the
district triannually (Figure 1). The RODRS program visits 11
remote communities in the district annually. These remote
communities have nurse-led clinic facilities with visiting
general practice services and three communities have visiting
optometry and ophthalmology services. The documented
diabetic population in each community ranges from 3 to 49
people and is listed in Table 1.
Locations of visiting optometry and ophthalmology services
Figure 1: Remote communities visited by the RODRS program
(listed 1 to 11).
2.2. Service Promotion and Patient Identification. Figure 2
presents a graphical representation of the outreach screening
process. Diabetic patients are identified from a State Health
chronic disease database. Patient lists are then sent to each
primary health care centre (PHC) and the regional diabetes
educator, who adjusts lists adding patients and removing
those no longer living in the district. Diabetic patients are
contacted by community health from the rural hub or by their
local PHC to invite them for annual screening. Posters are
displayed in community public areas and local healthworkers
raise awareness of the screening visit. On the day of screening,
local health workers visit residents in their homes to remind
them of the visiting service and provide transport to clinics if
required.
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Figure 2: The remote outreach DR screening pathway.
2.3. ScreeningVisit. A registered nurse and Indigenous health
worker (Indigenous refers to Aboriginal peoples and/or
Torres Strait Islanders) (IHW) based in the rural hub travel
via four-wheel drive to 11 remote communities with a fundal
camera. This forms part of an existing chronic disease
network in the district. Remote communities are located
between 117 km and 693 km (approximately 1.5 to 7 hours’
drive) from the rural hub, which itself is located 687 km
from the closest major regional hospital and 1176 km from
the state capital [16]. DR screening is performed in PHCs
(except for one community where it is hospital-based). A
brief patient history, random blood glucose level (BGL),
HbA1c, cholesterol level, blood pressure (BP), and body
mass index (BMI) are collected. A visual acuity using a
Snellen chart is then performed, with pinhole if required.
Patients then undergo fundal photography by a registered
nurse using an automated nonmydriatic camera (centervue
DRS). One 45∘ fundal photograph centred on the macula and
with view of the optic nerve is captured of each eye. If an
adequate image cannot be acquired, patients undergo dilation
with tropicamide (Mydriacyl) 0.5% unless contraindicated. A
visiting diabetes educator, podiatrist, anddietician also attend
most remote clinics to provide a comprehensive diabetes
service.
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2.4. ImageGrading and Feedback of Results. Clinical informa-
tion and fundal images are transferred to an urban, regional,
or locally based rural general practitioner (GP) accredited to
performDR image grading (fourGPs involved). Participating
GPs completed a four-hour online DR upskilling program
through The University of Queensland Masters of Medicine
(General Practice) program followed by an accreditation
assessment through The Royal Australian and New Zealand
College of Ophthalmologists (RANZCO) Queensland Fac-
ulty [17, 18]. GPs complete a 50-patient (100 eyes) exam and
must achieve at least 75% concordance with an ophthalmol-
ogist reviewer for accreditation [17, 18]. Accreditation was
provided through Flinders University for one participating
GP. For 2012-13 GP image grading was provided by a distant
accredited GP; however, in 2014 it was performed by a locally
based rural accredited GP, in collaboration with the visiting
ophthalmologist.
The GP grader assesses the adequacy of the image,
evaluates the image for the presence ofDRor other pathology,
grades DR (if present) according to the Wisconsin system,
and nominates an appropriate management plan (Figure 2)
[19]. An urban-based “buddy” ophthalmologist provides
support to the GP grader and visits the region triannually. If
no pathology is detected by the GP grader, screening results
are sent to the PHC for filing, with a copy sent to the patient.
If pathology is identified, results are sent to the PHC, the
patient, and the patient’s nominated GP to arrange oph-
thalmology referral. Those patients with mild or moderate
nonproliferative DR (NPDR) are referred to the visiting
ophthalmologist, to be seen during their triannual visit in
the community closest to them (Figure 2). The “buddy” oph-
thalmologist is notified of any patients with severe NPDR or
proliferative DR (PDR), and depending on the timing of their
next visit to the region, the patient will either be reviewed
by the regional ophthalmology team or urgently transferred
to a larger centre with permanent ophthalmology services.
Patients for whom an adequate image cannot be obtained are
generally referred to the visiting ophthalmologist, as this may
indicate another pathology such as cataract.
3. Method
3.1. Study Design. This retrospective, descriptive screening
record audit had three aims:
(i) to identify the proportion of patients with docu-
mented diabetes mellitus (type 1/type 2) residing in
11 remote communities who underwent DR screening
with the RODRS service,
(ii) to compare the proportion of those patients screened
by the program who underwent appropriate DR
screening prior to and following the implementation
of the RODRS service,
(iii) to identify the proportion of screened patients with
mild, moderate, or severe NPDR and PDR.
A further paper explores the acceptability of the program to
patients, health professionals, and other key stakeholders.
3.2. Setting and Participants. Data was collected at PHCs
during DR screening visits to 11 remote communities in a
state of Australia. Eligible participants were patients with
type 1 or type 2 diabetes mellitus aged 18 years or older,
attending DR screening in remote communities between
April 2012 and December 2014. Patients were excluded from
participation if they had no perception of light in either eye,
were terminally ill or deemed too unwell to participate, or had
a physical ormental disability that prevented either screening
or treatment. All eligible patients attending DR screening
clinics were invited to take part in the study and all patients
consented to participate (𝑛 = 142). However, one patient was
screened with gestational diabetes mellitus and therefore was
excluded from analysis. The Australian National Health and
Medical Research Council (NHMRC) developed national
guidelines for the recommended frequency of DR screening
[19].The guidelines recommend that all patientswith diabetes
(type 1 and type 2) undergo at least biennial screening.
However, patients at high risk of DR, including Indigenous
Australians and patients living in rural and remote commu-
nities, should be considered for annual examinations. In this
paper “appropriate” refers to screening frequency in line with
the NHMRC guidelines.
3.3. Intervention. The RODRS service was implemented in a
Hospital District and Health Service in 2012.
3.4. Outcomes. A retrospective analysis of State Health
screening data was conducted. The main outcome measures
included (i) the proportion of the documented diabetic
population living in remote communities who underwent
DR screening with the program, (ii) the proportion of
those patients screened by the program who underwent
appropriate screening (in line with the NHMRC guidelines
[19]) prior to and following the intervention, (iii) the quality
of images captured by the screening team, (iv) the proportion
of screening episodes with DR detected and the type of
DR identified, and (v) the proportion of screening episodes
which required ophthalmology referral. Clinical data on DR
screening prior to the intervention was based on self-report.
All other information was collected and accessed from State
Health records.
3.5. Analysis. All screening data were entered initially into
an Excel database, cleaned, and then imported into and
analysed using SPSS (version 22). Histograms were viewed
to assess the normality of continuous variables. Summary
statistics are presented as frequency (percentage) for categor-
ical variables and mean (standard deviation) for continuous
variables that were normally distributed; otherwise median
and interquartile ranges were reported. Where appropriate
Chi-square tests (gender, ethnicity, and DR detection in
high risk patients), Mann-Whitney 𝑈 (age, HbA1c), and an
independent sample 𝑡-test (systolic and diastolic BP) were
used to assess bivariate associations. A McNemar’s test was
performed to determine a 𝑝 value for proportions screened
prior to and following implementation of the model. A 𝑝
value of ≤0.05 was considered to be statistically significant.
3.6. Ethics Approval and Consent. In accordance with advice
from the Human Research Ethics Committee (HREC), the
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Figure 3: The proportion of the total documented diabetic popu-
lation (residing in 11 remote communities) screened each year with
95% confidence intervals shown.
above project was compliant with the NHMRC guidance
“ethical considerations in quality assurance and evalua-
tion activities” and therefore was not recommended for
HREC review (HREC/15/QRBW/122). Informed consent was
obtained from all participants.
4. Results
4.1. Diabetic Population Screened. A total of 218 screen-
ing episodes were recorded across 11 remote communi-
ties between April 2012 and December 2014. The program
screened 141 patients with 47 patients (33.3%) screened twice
and 15 patients (10.6%) screened three times. Of the 11 remote
communities visited by the screening team, eight communi-
ties were visited three times, two communities were visited
twice, and one community was visited once. The proportion
of the total documented diabetic population (residing in 11
remote communities) screened by the program significantly
increased throughout the operation of the service from 33.7%
in 2012 to 47.9% in 2014 (Table 1; Figure 3).The odds ratio for
being screened in 2014 compared with 2012 was 2 (95% CI
1.49–2.68; 𝑝 = 0.00003).
4.2. Participant Demographics. A total of 141 patients were
identified as eligible for participation in this study. Of these
58.2% of diabetic patients were male (Table 2). Indigenous
patients comprised 23.5% of patients screened, with most
Indigenous patients identifying as Australian Aboriginal.
Patients ranged from 18 to 90 years of age, with a median
age of 63 years. The median duration of diabetes was 6 years
with 32.1% of patients considered at high risk of DR (duration
of diabetes more than 10 years) [2, 20]. This is similar to the
national diabetes profile with diabetes slightly more common
in males than females (5.1% of males and 4.2% of females),
although the rate of diabetes is highest amongst those aged
Table 2: Participant demographics.
𝑛 = 141
Gender
Male 82 patients (58.2%)
Female 59 patients (41.8%)
Indigenous status
Non-Indigenous 101 patients (76.5%)
Indigenous
Australian Aboriginal 26 patients (19.7%)
Aboriginal & Torres Strait Islander 4 patients (3.0%)
South Sea Islander 1 patient (0.8%)
Total 31 patients (23.5%)
Age
Median 63 years
Interquartile range 19
Duration of diabetes
Median 6 years
Interquartile range 9
Duration >10 years 45 patients (32.1%)
Note: one missing record for duration of diabetes, nine missing records for
Indigenous status.
Table 3: Clinical characteristics based on total screening episodes.
𝑛 = 218
HbA1c
Median 7.1%
Interquartile range 2
HbA1c ≥7% 71 patients (51.8%)
HbA1c ≥8% (high risk of DR) 39 patients (28.5%)
Hypertension
Systolic BP
Mean ± SD 140.5mmHg (±20.3)
≥130mmHg 97 patients (69.8%)
≥150mmHg (high risk of DR) 36 patients (25.9%)
Diastolic BP
Mean ± SD 82.9mmHg (±12.0)
≥85mmHg 64 patients (46.0%)
≥90mmHg (high risk of DR) 45 patients (32.4%)
Note: four patients were missing one to two data variables.
75 to 84 years, slightly older than the population screened in
this study [21].
4.3. Clinical Characteristics. The median HbA1c of diabetic
patients screened by the program was 7.1%. Overall, 51.8%
of patients had an HbA1c ≥ 7% indicating poor glycaemic
control and 28.5% of patients had an HbA1c ≥ 8% (associated
with increased risk of DR) (Table 3) [2, 20, 22]. Systolic BP
ranged from 100mmHg to 212mmHg with a mean systolic
BP of 140.5mmHg. Diastolic BP ranged from 54mmHg to
120mmHg, with an average diastolic BP of 82.9mmHg.Most
patients had suboptimal BP control with 69.8% of patients
with a systolic BP reading ≥ 130mmHg and 46% of patients
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30.5%
16.3%
15.5% 1.5% 36.2%
DR screening prior to the implementation of the RODRS
service
No prior DR screening
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1–<5 years
Figure 4: Patient reported DR screening prior to the implementa-
tion of the model (𝑛 = 141). Note: unknown included those patients
who were not aware if they had undergone screening previously and
those who had undergone screening but were unsure of the date.
with a diastolic BP ≥ 85mmHg [22]. In addition, many
patients were considered at high risk of DR with a systolic BP
≥ 150mmHg (25.9%) or a diastolic BP ≥ 90mmHg (32.4%)
[2, 20].
4.4. DR Screening Rates. Of the 141 patients screened by
the program, 16.3% had received appropriate DR screening
prior to the implementation of the service (screening in line
with recommendations made in the NHMRC guidelines),
but 36.2% of patients had never been screened (Figure 4)
[19]. Following the introduction of the program, 66.3% of
eligible patients received appropriate screening (odds ratio
1.93; 95% CI of 1.42–2.64; 𝑝 = 0.00025). (Note: A total
of 92 patients were included in the analysis of appropriate
screening following the implementation of the model (49
patients excluded). A total of 36 patients were excluded as
rescreening could not be evaluated for the following reasons:
(i) screened in a community only visited once by the program
(one community), (ii) screened for the first time in 2014, or
(iii) screened for the first time in 2013 in those communities
not visited in 2014 (two communities). A further 13 patients
who were deceased or had moved from the community were
excluded.) Commonly recorded reasons for not attending
community screening included previous screening by an
ophthalmologist or optometrist, working or travelling out
of town, illness/hospitalisation, or unable to be contacted.
There was no significant difference between those patients
who underwent appropriate screening with the model based
on gender (1.216; 1 df; 𝑝 = 0.27), Indigenous status (0.007;
1 df; 𝑝 = 0.93), age (𝑧 = −1.84; 𝑝 = 0.07), HbA1c (𝑧 = −0.37;
𝑝 = 0.71), systolic BP (𝑡 = −0.29; 𝑝 = 0.77), or diastolic BP
(𝑡 = −0.74; 𝑝 = 0.46).
4.5. Image Quality. A total of 13.9% of screening episodes
required rescreening due to inadequate images (Table 5).
Further analysis demonstrated that the vast majority of
2012 2013 2014
5.9%
26.5%
6.0%
Screening episodes with inadequate images
Figure 5: The proportion of screening episodes requiring rescreen-
ing due to inadequate images (according to GP management plan)
by year.
Table 4: Appearance of fundi (GP grader).
Left eye Right eye Screening episodes
(𝑛 = 218) (𝑛 = 218) (𝑛 = 218)
𝑛 (%) 𝑛 (%) 𝑛 (%)
No DR detected 142 (66.7%) 143 (66.2%) 126 (58.9%)
DR detected
Mild NPDR 22 (10.3%) 24 (11.1%) 27 (12.6%)
Moderate NPDR 11 (5.2%) 14 (6.5%) 18 (8.4%)
Severe NPDR 2 (0.9%) 1 (0.5%) 2 (0.9%)
Proliferative DR 5 (2.3%) 1 (0.5%) 5 (2.3%)
Total detected 40 (18.7%) 40 (18.5%) 52 (24.3%)
Inadequate image 31 (14.6%) 33 (15.3%) 36 (16.8%)
Note: data was missing from two to five records.
Note: where the diagnosis differed between images of the right eye and left
eye, the screening episode was categorised according to the most serious
diagnosis. Where a patient had one inadequate image and the other image
identified DR, the screening episode was categorised as DR.
inadequate images occurred in 2013, with a rate as high as
26.5% of screening episodes (Figure 5) and traced to a faulty
camera. Following camera servicing, this decreased to 6% of
screening episodes.
4.6. Diabetic Retinopathy Detection and Referral. Table 4
describes the proportion of screening episodes where images
were normal, abnormal, or inadequate and required reimag-
ing. A total of 58.9% of screening episodes were normal,
24.3% had DR detected, and 16.8% produced inadequate
images. The majority of patients with DR had mild to
moderate NPDR detected (21%); however, in 3.2% of screen-
ing episodes sight-threatening DR was detected (defined
by severe NPDR or PDR). GP graders identified diabetic
maculopathy in 5.6% of screening episodes, with all cases
detected in 2014.
There was no statistically significant association between
detection of DR and the absence or presence of appropriate
DR screening prior to the implementation of the service
(0.525; 1 df; 𝑝 = 0.47). DR was detected more often in
patients with a duration of diabetes more than 10 years and
an HbA1c ≥ 8%, cut-offs previously shown to increase the
risk of DR [2, 20]. A total of 51.6% of patients with diabetes
longer than 10 years had DR detected, compared with 25.2%
of patients with no DR detected (7.798; 1 df; 𝑝 = 0.005). In
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Table 5: GP management plan.
Screening episodes
(𝑛 = 218)
𝑛 (%)
No action 125 (57.9%)
Ophthalmology referral
Refer to “buddy” ophthalmologist 55 (25.5%)
Urgent referral 6 (2.8%)
Total 61 (28.2%)
Inadequate image 30 (13.9%)
Note: data was missing from two records.
Note: where the management plan differed between the right and the left
eyes, the screening episode was categorised according to the most urgent
management plan. Where a patient had one inadequate image and the other
image identified pathology requiring ophthalmology referral, the screening
episode was categorised as an ophthalmology referral.
Note: differences in the number of patients with inadequate images between
Tables 4 and 5 is due to some patients being identified for ophthalmology
referral due to detection of another pathology.
screening episodes where the patient’s HbA1c was ≥8%, DR
was detected more often (47.1%, compared to 23.4% with no
DR) (10.602; 1 df; 0.001). There was no statistically significant
association between a diastolic BP ≥ 90mmHg (0.363; 1 df;
𝑝 = 0.547) or a systolic BP ≥ 150mmHg (3.447; 1 df; 𝑝 =
0.063) and detection of DR.
A total of 28.2% of screening episodes were referred to
the “buddy” ophthalmologist for review of DR or secondary
to identification of another pathology. This included 2.8% of
screening episodes for urgent referral (Table 5).
4.7. Other Pathology. Pathology other than DR was detected
in 15.1% of screening episodes. Cataract was the most com-
monly identified pathology and clouded fundal photographs.
Macular degeneration and hypertensive retinopathy were
also detected.
5. Discussion
The implementation of the RODRS service has significantly
improvedpatient access toDR screening.Appropriate screen-
ing has quadrupled from 16.3% to 66.3% of patients. This
is above the national population average for appropriate
DR screening and is a significant achievement in remote
populations with minimal to no access to optometry and
ophthalmology services [6]. Since the introduction of the
program, screening of the eligible diabetic population living
in remote communities has become more comprehensive,
increasing from 33.7% to 47.9% across its three years of
operation. International rural and remote DR screening
programs reported population coverage ranging from 39%
to 85% [23–31]. Indeed, achieving high rates of screening is
particularly challenging in these study communities given
the transient and highly mobile nature of the population, the
fact that patients are often employed away from townships,
the delivery of screening only once annually, and the lack
of a fully coordinated approach to screening with visiting
optometry and ophthalmology services. Low health literacy
and limited patient contact with local health services are also
recognised barriers to achieving comprehensive population
coverage. It is hoped that with continued service promotion
and improved community awareness, patient uptake will
continue to improve.
Despite limited ophthalmology resources, a review of
international rural remote DR screening models by the
authors found that the majority of programs use ophthal-
mologists as the primary image graders. Most countries are
not adequately meeting screening recommendations and the
number of people with diabetes continues to rise [6, 7,
32, 33]. Further to this, evidence suggests that on average
70% of fundal images captured show no retinopathy [17].
There is thus a need to explore innovative approaches to DR
screening within a range of settings. Previous studies have
demonstrated the efficacy of GP graders, with an Australian
pilot of DR grading by general practitioners demonstrating
good sensitivity (87%) and specificity (95%) [11]. During
the operation of the RODRS service, just 28.2% of patients
required ophthalmology referral for DR. This model may
thus provide a more efficient solution to managing limited
specialist ophthalmology resources in rural and remote areas.
Many international rural remote DR screening models
have identified the successful integration of screen-positive
patients with ophthalmology follow-up to be particularly
challenging [34, 35]. A benefit of the RODRS program is
the integration of screen-positive patients with specialist
follow-up through the use of a “buddy” ophthalmologist,
who supports the GP grader and provides visiting services
to the region. The RODRS program also integrated DR
screening with other diabetes care, providing a holistic
multidisciplinary diabetes service that enables patients to
easily complete their annual cycle of care. The significance
of this is demonstrated by data released by the National
Diabetes Strategic Advisory Group indicating that just 18%
of Australian diabetics had a claim made by their GP for
an annual cycle of care [36, 37]. It is hoped that provision
of a coordinated approach to diabetes care will increase
the proportion of diabetic patients undergoing annual DR
screening and completing their annual cycle of care.
The RODRS service is inherently unique in its delivery,
using local health professionals to screen diabetic patients
and a local GP to grade images. This community-based
approach enables the service to tailor itself to the needs of
the local population and workforce. Also notable are the high
screening rates amongst the Indigenous population, com-
prising 23.5% of patients screened. Providing a service that
meets the needs of the local Indigenous community is vitally
important given that just 20% of Indigenous Australians
undergo appropriate DR screening and rates of blindness are
six times higher than for non-Indigenous Australians [10].
DR was detected in 24.3% of screening episodes. This is
consistent with other rural remote Australian studies with
reported detection rates ranging from 11% to 45%, but with
the majority of programs reporting rates of 16 to 18% [23, 24,
38, 39]. This is significant and exemplifies the benefits of the
program in detecting abnormality and avoiding preventable
blindness. Diabetic maculopathy was identified in 5.6% of
screening episodes. All cases were detected in 2014, following
8 Journal of Diabetes Research
a changeover of GP graders. This could be explained by dif-
fering terminology amongst GP graders, with some graders
believing they should only report diabetic macula oedema.
Other Australian rural remote models have reported rates of
diabetic macula oedema ranging from 0.2% to 2.8%, whilst
international studies reported rates of clinically significant
macula oedema ranging from 4.4% to 6.1% [23, 28, 38, 40–
42].
The recent release of the consultation paper for the
development of the AustralianNational Diabetes Strategy has
highlighted improved eye screening as a key challenge for
the future [36]. Models such as this one provide a successful
approach both to screening and comprehensive ongoing
management of patients with DR. Further research is needed
to identify the generalisability of thismodel in terms of infras-
tructure, payment models, and incentives for quality. The
Australian Medical Services Advisory Committee (MSAC),
the group that advises government on additional medical
services nationally, has recently recommended a Medicare
Benefits Schedule (MBS) item number for nonmydriatic
retinal photography in primary care settings, significantly
improving the feasibility of this model of care in Australian
communities [43].
6. Limitations
Some patient records were missing clinical information.
No data was available on the proportion of screen-positive
patients who actually underwent follow-up by an ophthal-
mologist.
7. Conclusion
Given the increasing number of remote Australians with
diabetes, the development and trial of efficient workforce
solutions for DR screening are of growing importance. This
innovative model has significantly improved patient access
to DR screening. It utilises existing infrastructure and the
local health workforce to develop a community-driven and
delivered service that meets the needs of the local population.
It integrates DR screening into an already existing multi-
disciplinary diabetes service, providing comprehensive and
holistic diabetes care.
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